51 – 100 of 109
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
Discordant amyloid-β PET and CSF biomarkers and its clinical consequences
(
- Contribution to journal › Article
- 2018
-
Mark
Prion-like seeding and nucleation of intracellular amyloid-β
(
- Contribution to journal › Article
-
Mark
Amyloid pathology in the progression to mild cognitive impairment
(
- Contribution to journal › Article
-
Mark
Fluid Biomarkers in Alzheimer’s Disease and Frontotemporal Dementia
2018) p.221-252(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
The National Institute on Aging and the Alzheimer's Association Research Framework for Alzheimer's disease : Perspectives from the Research Roundtable
(
- Contribution to journal › Scientific review
-
Mark
Amyloid network topology characterizes the progression of Alzheimer's disease during the predementia stages
(
- Contribution to journal › Article
-
Mark
Sex-specific genetic predictors of Alzheimer’s disease biomarkers
(
- Contribution to journal › Article
-
Mark
Prevalence of the apolipoprotein E ε4 allele in amyloid β positive subjects across the spectrum of Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
Preparation and culturing of human primary vascular cells
(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
On the role of sidechain size and charge in the aggregation of Aβ42 with familial mutations
2018) In Proceedings of the National Academy of Sciences of the United States of America 115(26). p.5849-5858(
- Contribution to journal › Article
-
Mark
Abnormal structural brain connectome in individuals with preclinical Alzheimer's disease
(
- Contribution to journal › Article
- 2017
-
Mark
Increased blood-brain barrier permeability is associated with dementia and diabetes but not amyloid pathology or APOE genotype
(
- Contribution to journal › Article
-
Mark
The human serum protein C4b-binding protein inhibits pancreatic IAPP-induced inflammasome activation
(
- Contribution to journal › Article
-
Mark
Involvement of endosomal and synaptic Aβ in models of Alzheimer's disease.
2017)(
- Thesis › Doctoral thesis (compilation)
-
Mark
Ponezumab in mild-to-moderate Alzheimer's disease : Randomized phase II PET-PIB study
2017) In Alzheimer's and Dementia: Translational Research and Clinical Interventions 3(3). p.393-401(
- Contribution to journal › Article
-
Mark
Recommendations for cerebrospinal fluid collection for the analysis by ELISA of neurogranin trunc P75, α-synuclein, and total tau in combination with Aβ(1-42)/Aβ(1-40)
(
- Contribution to journal › Article
-
Mark
Cerebrovascular and amyloid pathology in predementia stages : The relationship with neurodegeneration and cognitive decline
(
- Contribution to journal › Article
- 2016
-
Mark
Optimized Standard Operating Procedures for the Analysis of Cerebrospinal Fluid Aβ42 and the Ratios of Aβ Isoforms Using Low Protein Binding Tubes
(
- Contribution to journal › Article
-
Mark
Assessing risk for preclinical β-amyloid pathology with APOE, cognitive, and demographic information
(
- Contribution to journal › Article
-
Mark
Analysis of the length distribution of amyloid fibrils by centrifugal sedimentation
(
- Contribution to journal › Article
- 2014
-
Mark
The chaperone domain BRICHOS prevents CNS toxicity of amyloid-beta peptide in Drosophila melanogaster
(
- Contribution to journal › Article
-
Mark
Fertility Defects in Mice Expressing the L68Q Variant of Human Cystatin C A ROLE FOR AMYLOID IN MALE INFERTILITY
(
- Contribution to journal › Article
-
Mark
Conformational and aggregation properties of the 1-93 fragment of apolipoprotein A-I
(
- Contribution to journal › Article
-
Mark
Anti-amyloid compounds inhibit α-synuclein aggregation induced by protein misfolding cyclic amplification (PMCA)
(
- Contribution to journal › Article
- 2013
-
Mark
Fluid biomarkers in Alzheimer's disease - current concepts
(
- Contribution to journal › Scientific review
-
Mark
Molecular Mechanisms in Amyloid Disorders. Novel Treatment Options in Hereditary Cystatin C Amyloid Angiopathy.
(
- Thesis › Doctoral thesis (compilation)
-
Mark
A beta 1-15/16 as a Potential Diagnostic Marker in Neurodegenerative Diseases
(
- Contribution to journal › Article
- 2012
-
Mark
Distinct phases of free α-synuclein - A Monte Carlo study.
(
- Contribution to journal › Article
-
Mark
Intraneuronal A beta Accumulation, Amyloid Plaques, and Synapse Pathology in Alzheimer's Disease
(
- Contribution to journal › Article
-
Mark
Monte Carlo studies of protein aggregation
(
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
-
Mark
Isolation of Amyloid by solubilization in water
(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Critical role of intraneuronal A beta in Alzheimer's disease: Technical challenges in studying intracellular A beta
(
- Contribution to journal › Article
- 2011
-
Mark
Monte Carlo Study of the Formation and Conformational Properties of Dimers of Aβ42 Variants.
(
- Contribution to journal › Article
-
Mark
Cerebrospinal Fluid Biomarkers for Alzheimer's Disease: Diagnostic Performance in a Homogeneous Mono-Center Population
(
- Contribution to journal › Article
- 2010
-
Mark
Amyloid beta-Protein Aggregation Produces Highly Reproducible Kinetic Data and Occurs by a Two-Phase Process
(
- Contribution to journal › Article
-
Mark
Dual Effect of Amino Modified Polystyrene Nanoparticles on Amyloid beta Protein Fibrillation
(
- Contribution to journal › Article
-
Mark
Crystal structure of human cystatin C stabilized against amyloid formation
(
- Contribution to journal › Article
-
Mark
Converging Pathways of Chromogranin and Amyloid Metabolism in the Brain
(
- Contribution to journal › Article
-
Mark
Synapses, synaptic activity and intraneuronal Aβ in Alzheimer's disease
(
- Contribution to journal › Scientific review
-
Mark
Intraneuronal β-amyloid accumulation and synapse pathology in Alzheimer's disease
(
- Contribution to journal › Scientific review
-
Mark
Co-occurrence of Alzheimer's disease β-amyloid and tau pathologies at synapses
(
- Contribution to journal › Article
- 2009
-
Mark
International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders
(
- Contribution to journal › Scientific review
-
Mark
A facile method for expression and purification of the Alzheimer's disease-associated amyloid beta-peptide
(
- Contribution to journal › Article
-
Mark
Triterpenoid CDDO-methylamide improves memory and decreases amyloid plaques in a transgenic mouse model of Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
Dementia
2009) p.403-408(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Immunotherapy for Alzheimer disease
(
- Contribution to journal › Article
- 2007
-
Mark
Nucleation of protein fibrillation by nanoparticles
(
- Contribution to journal › Article
- 2006
-
Mark
Lactadherin binds to elastin - a starting point for medin amyloid formation?
(
- Contribution to journal › Article
- 2005
-
Mark
3D domain-swapped human cystatin c with amyloidlike intermolecular beta-sheets
(
- Contribution to journal › Article
-
Mark
Beta-amyloid accumulation in APP mutant neurons reduces PSD-95 and GluR1 in synapses
(
- Contribution to journal › Article